Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.

Oncotarget · 2017 · PMC5589655 · PMID 28903416

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly non-significantno p-value reported

Sunitinib treatment in a concentration of 0.5 μM resulted in an enhanced, but slightly non-significant, activity of AKT and a significant enhanced activity of all other signaling molecules investigated.

also in 109 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.